Knight Therapeutics Inc. (TSX:GUD)
6.82
+0.41 (6.40%)
At close: Mar 23, 2026
Knight Therapeutics Employees
Knight Therapeutics had 745 employees as of December 31, 2024. The number of employees increased by 20 or 2.76% compared to the previous year.
Employees
745
Change (1Y)
20
Growth (1Y)
2.76%
Revenue / Employee
604.14K CAD
Profits / Employee
-7.21K CAD
Market Cap
668.60M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 745 | 20 | 2.76% | 745 | 0 |
| Dec 31, 2023 | 725 | 27 | 3.87% | 725 | 0 |
| Dec 31, 2022 | 698 | 38 | 5.76% | 698 | 0 |
| Dec 31, 2021 | 660 | -19 | -2.80% | 660 | 0 |
| Dec 31, 2020 | 679 | - | - | 679 | 0 |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Trulieve Cannabis | 5,000 |
| Green Thumb Industries | 5,000 |
| Verano Holdings | 3,800 |
| Cresco Labs | 2,900 |
| Organigram Global | 1,137 |
| Aurora Cannabis | 1,073 |
| TerrAscend | 1,038 |
| Canopy Growth | 960 |
Knight Therapeutics News
- 1 day ago - Knight Amends Normal Course Issuer Bid - GlobeNewsWire
- 3 days ago - Investor Outlook: Knight Therapeutics beats estimates on product growth - BNN Bloomberg
- 4 days ago - Knight Therapeutics Inc (KHTRF) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... - GuruFocus
- 4 days ago - Q4 2025 Knight Therapeutics Inc Earnings Call Transcript - GuruFocus
- 4 days ago - Knight Therapeutics Inc. (GUD:CA) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Knight Therapeutics Reports Fourth Quarter and Year-End 2025 Results - GlobeNewsWire
- 7 days ago - Knight Therapeutics Wins Approval Of Additional Indication For MINJUVI In Brazil - Nasdaq
- 12 days ago - Notice of Knight Therapeutics’ Fourth Quarter and Year End 2025 Results Conference Call - Financial Post